Is it normal to take Eltrombopag/Eltrombopag Platelet 800?
Eltrombopag is an oral thrombopoietin receptor agonist, mainly used to treat thrombocytopenia caused by chronic immune thrombocytopenia (ITP) and other diseases. It increases platelet production by stimulating the thrombopoietin receptor (TPO-R), promoting the proliferation and differentiation of megakaryocytes in the bone marrow. The use of eltrombopag could help patients who are at risk of bleeding due to low platelet counts, especially if other treatments have failed.
Concerning the normal range of platelet levels after taking eltrombopag, it is important to understand the target platelet value and the purpose of using eltrombopag. Normally, the number of platelets in a healthy adult is approximately 150,000 to 450,000/microliter. However, in some patients, especially those with chronic idiopathic thrombocytopenia, platelet numbers tend to fall below this normal range, so the goal of treatment is to increase platelet numbers to a sufficient level to reduce the risk of bleeding.
While taking eltrombopag, your doctor will usually monitor your platelet levels regularly to make sure your platelet count is meeting your treatment goals. A platelet count of 800,000/microliter, while not necessarily dangerous, is above the upper limit of the normal range and may require adjustments to treatment. During treatment, too high platelet levels may increase the risk of thrombosis, so if platelet counts are too high, you may need to consider reducing the dose of eltrombopag or discontinuing the drug.
The increase in platelet count is not only related to the use of eltrombopag, but may also be related to individual differences in patients, the type of underlying disease, the combined use of other drugs during treatment, and other factors. In some cases, excessively increased platelet counts may lead to adverse clinical consequences, such as thrombotic complications, so platelet monitoring is particularly important during treatment.
Reference materials:https://go.drugbank.com/drugs/DB06210
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)